MEDIA
RSF IN THE NEWS
Pioneering Clergy of Diverse Religions Embrace Psychedelics, April 20, 2022
Religious professionals participated in a yet-to-be published study by researchers at Johns Hopkins and NYU.
“We’ve lost touch with how to connect to primary religious experience,” she said. “Modern traditions, especially the Abrahamic traditions, are spooked by it. Christianity has burned people at the stake and killed off indigenous traditions for saying (psychoactive) plants can show us another realm of being. It goes deep.”
Psilocybin study enrolls clinicians with COVID-linked blues, December 13, 2021
The UW Medicine trial aims to detect whether psychedelic-assisted psychotherapy helps to alleviate depression and burnout.
“We’re looking for doctors, nurses and advance-practice providers who have clinically significant symptoms of depression and anxiety. We hope to help them address their feelings of grief, inadequacy and moral distress as a result of caring for COVID patients,” said Dr. Anthony Back, the lead investigator.
Organic Inside
April 27, 2019
"Why Sun+Earth and Brother David’s are So Vital for Organic Stakeholders and Our Planet."
"Brother David's envisions a world when all our family ecosystems are regenerative and organic. Producing our food, clothes, personal care and medicines in ways that support thriving rural economies and biodiverse wild habitats."
Inside Philanthropy
February 13, 2019
"Riverstyx: A Small Family Foundation That Funds Psychedelic Research and Other Fringe Causes."
“Often when we push things out, that’s when they become problematic. Actually bringing them into the fold of society and our consciousness has great power,” Swift says.
STAT News
December 1, 2016
"Magic mushrooms drug shown to ease cancer patients’ depression"
Two studies published Thursday in the Journal of Psychopharmacology — one conducted at Johns Hopkins University and the other at New York University — found that a single dose of psilocybin, the psychoactive ingredient found in hallucinogenic mushrooms, can produce immediate, lasting, and positive effects for cancer patients with anxiety and depression.
Seattle Pi
October 1, 2012
"A $4 million marijuana campaign war chest"
"The campaign war chest for Initiative 502, which would legalize marijuana, swelled by more than $1 million on Monday with new donations from an Ohio insurance magnate and two executives of the Kirkland-based Riverstyx Foundation a family-underwritten foundation which, in its own words, supports “attempts to lessen human suffering caused by fear and misguided social policy.”"
The Emergent Field of Psychedelic Chaplaincy, April 19, 2022
Chaplains are stepping up to fill the gap left by medical & psychological models, carving out a space to compassionately support individuals through their spiritual and existential challenges catalyzed by psychedelics.
For Petersen, psychedelic chaplaincy presents itself as a form of spiritual harm reduction in the current paradigm of psychedelic research. “What’s missing is a rigorous and grounded approach for how to hold space for people to reckon with the epistemological and ontological questions that can arise but not always do arise.”
The Jewish News of Northern California
April 12, 2021
The first ever Jewish Pyschedelic Summit is about to take off
"Kamenetz has a vision. He dreams of a world in which the trauma of the Jewish past can be healed through psychedelic experiences, a world in which chemically assisted mystical encounters are a normative part of Jewish spirituality."
KNKX
April 27, 2019
"The government won’t pay for research into psychedelic drugs. Cody Swift will."
"How does a research study get funded? The most common way is to apply for a grant from the government. But what if what you’re studying is so controversial that government funders won't touch it?"
The Stranger
March 8, 2017
"Some say taking small amounts of LSD or psychedelic mushrooms can decrease depression, anxiety, and chronic pain."
"So much is happening on a level beyond our consciousness," Swift says. "It showed me that this is not just a recreational tool. It's a profound tool for understanding the mind."
Spring 2016
"Psychedelic Philanthropy: Making Medicines and Reclaiming Time"
"Psychedelics not only have the potential to work at the root level of psychological issues, but if we accept that almost all social problems are psychological in themselves, then psychedelics may help to address the source of almost every other philanthropic effort—from environmental devastation to the volatility in our economic system."
Funders at Johns Hopkins Shape The Future of Psychedelic Research, April 8, 2022
Until recently, philanthropists paid for virtually all of the research into psychedelics.
Pioneering donors including Ferriss, Jesse, businessman Carey Turnbull, T. Cody Swift of the Riverstyx Foundation, and the nonprofit Heffter Research Institute were indispensable in the early years of psilocybin research. “These are the people who have been keeping the flame alive through the darkest years,” Johnson says.
Psychedelics Today
October 22, 2019
RiverStyx – Funding the Access and Preservation of Sacred Plant Medicines
"In the west we need to redevelop healthy relationships with these plants - yes they can be dangerous and risky, but that's where relationship is, where we respect those edges. RiverStyx is looking into how to help put a lot of these plant medicines back into a place of honor and respect."
VOA News
March 9, 2019
"Native American Church Works to Conserve, Sustain Peyote."
“It’s about generations to come,” said Iron Rope. “To reconnect them to the land and to the medicine. And that’s the healing process that we’ve been missing.”
Don Lattin,
Spring, 2017
"Psychedelic Sacraments and the New Psychotherapy"
"I absolutely loved the guiding work. As a psychologist, there's no other venue where you can see the nature of true psychological healing unfold over this short period of time. You feel transcendent love leading to changes in perspective."
C&EN
March 28, 2016
"Psychedelic compounds like esctacy may be good for more than just a high"
"Scientists are testing whether drugs that alter consciousness can treat intractable mental health conditions... Potential applications include treating addiction, post traumatic stress disorder, neuropathic pain, epilepsy, and anxiety caused by diagnosis of a life-theratening illness such as cancer."
